LifeStance Health Group, Inc. Stock

Equities

LFST

US53228F1012

Healthcare Facilities & Services

Market Closed - Nasdaq 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
6.11 USD +4.09% Intraday chart for LifeStance Health Group, Inc. +8.72% -21.97%
Sales 2024 * 1.22B Sales 2025 * 1.38B Capitalization 2.33B
Net income 2024 * -104M Net income 2025 * -76M EV / Sales 2024 * 2.06 x
Net Debt 2024 * 186M Net Debt 2025 * 117M EV / Sales 2025 * 1.77 x
P/E ratio 2024 *
-21.5 x
P/E ratio 2025 *
-28.2 x
Employees 9,325
Yield 2024 *
-
Yield 2025 *
-
Free-Float 26.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.09%
1 week+8.72%
Current month-0.97%
1 month+3.04%
3 months-11.71%
6 months+17.27%
Current year-21.97%
More quotes
1 week
5.62
Extreme 5.615
6.16
1 month
5.62
Extreme 5.615
6.47
Current year
4.74
Extreme 4.735
9.20
1 year
4.74
Extreme 4.735
9.59
3 years
4.22
Extreme 4.22
29.81
5 years
4.22
Extreme 4.22
29.81
10 years
4.22
Extreme 4.22
29.81
More quotes
Managers TitleAgeSince
Founder 39 16-12-31
Chief Executive Officer 65 22-09-06
Director of Finance/CFO 55 22-11-09
Members of the board TitleAgeSince
Chief Executive Officer 65 22-09-06
Director/Board Member 50 16-12-31
Director/Board Member 51 16-12-31
More insiders
Date Price Change Volume
24-04-23 6.11 +4.09% 1,893,754
24-04-22 5.87 +2.80% 1,071,433
24-04-19 5.71 0.00% 859,166
24-04-18 5.71 +0.35% 801,524
24-04-17 5.69 +1.25% 670,715

Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT

More quotes
LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
6.11 USD
Average target price
8.786 USD
Spread / Average Target
+43.79%
Consensus